The CSP repeat is of broad interest for malaria vaccine design because it is targeted by inhibitory antibodies capable of preventing sporozoite infection as the parasite transits from Anopheles mosquitoes to mammalian hosts. This evidence concerns the gene DNAJC5 and malaria.